| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $39.00B | +15.6% |
| Cost of Revenue | $21.04B | +6.7% |
| R&D Expense | $2.93B | +9.3% |
| SG&A Expense | $1.70B | -1.1% |
| Operating Income | $10.42B | +49.8% |
| Pre-tax Income | $9.97B | +60.6% |
| Income Tax | $1.25B | +57.3% |
| Net Income | $8.71B | +61.1% |
| EPS (Basic) | $20.28 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.80B | +9.7% |
| Short-term Investments | $1.78B | +8382.4% |
| Current Assets | $13.10B | +32.1% |
| Total Assets | $53.63B | +10.1% |
| Current Liabilities | $10.76B | +21.4% |
| Long-term Debt | $13.80B | -2.4% |
| Total Liabilities | $28.89B | +2.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.36B | +1.2% |
| Capital Expenditures | $439.5M | +26.1% |
| Investing Cash Flow | -$2.18B | -502.7% |
| Financing Cash Flow | -$4.07B | +31.5% |
| Free Cash Flow | $6.92B | -0.1% |
| +65.6% |
| EPS (Diluted) | $19.83 | +64.8% |
| Stockholders' Equity |
| $24.74B |
| +20.2% |